Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Intuitive Surgical, Inc. (ISRG): Get 25% Upside With This ‘Cyborg In The Operating Room’

Page 1 of 2

Even after the tech-craze and bubble of the ’90s, technological leaps still change our lives drastically and offer the most compelling cases for amazing profits.

After researching stocks for my recent series on the “Graying of America,” I was well aware of the demographic forces behind the health care industry.

The numbers forecast for the health care industry over the next decade are staggering. Total U.S. health care spending is projected to reach $4.8 trillion in 2021, 84% higher than current spending. More than 10,000 baby boomers turn 65 each day, and life expectancy has reached 79 years. These drivers are going to create a lot of opportunities in the sector, and technology is just beginning to play a part.

That is why I am so excited about one company in particular — one I like to call the cyborg of the operating room.

Da Vinci Meets ‘The Terminator’

Long recovery times and hospital stays associated with major surgery are a big contributor to the high cost of health care. The average hospital stay after invasive surgery is up to seven days, with the average cost per day approaching $4,000 in many states.

And the recovery time after hospitalization can take weeks because the only way to do many of these operations is to open up the patient, which leaves the patient at risk of infection and other complications.

That is, until this company invented a revolutionary new machine, one that combines the art of a surgeon’s scalpel with 21st-century robotics.

Enter Intuitive Surgical, Inc. (NASDAQ:ISRG) and Da Vinci, a robotic arm that allows surgeons to operate with just a single incision less than an inch in size.

With the Da Vinci robot, surgeons no longer need to remove organs to perform an operation, so recovery time is shortened, sometimes to as little as one day.

Surgeons no longer need to remove organs to perform an operation, so recovery time is shortened, sometimes to as little as one day. Research has also shown that surgeries using Da Vinci have a lower risk of complications and lower incidence of infection.

There were 2.6 million procedures done last year that could have used the Da Vinci technology, but only 450,000 were done using the apparatus. That amounts to 17% penetration of a market with some strong demographic growth drivers ahead.

Costly Procedures, Cheap Stock

While the technology helps to bring down costs and risks after the procedure, the equipment is not cheap to buy. In fact, the system costs between $1 million and $2.3 million with instruments, costing about $2,000 per procedure.

That’s why the stock has taken a hit lately as the government rails against the high cost of medical care. Intuitive Surgical, Inc. (NASDAQ:ISRG) is down 35% from its February high on fear that the Affordable Care Act will limit the amount paid for procedures and doctors’ ability to recommend them.

Even with the slower capital spending environment, procedures were up 25% in 2012, and revenue growth has increased at a compound annual rate of 29% over the past five years. The equipment is expensive, but hospitals are still finding room in their budgets for Da Vinci’s revolutionary potential. Once the spending cycle for medical equipment recovers, Intuitive Surgical, Inc. (NASDAQ:ISRG)’s sales could jump.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!